NOV. 28, 2006: CYTOREX BIOSCIENCES GETS US PATENT NO. 7,141,251 ON IT'S ANTI-CANCER DRUG “CYTOREG®”

SOUTH FLORIDA BUSINESS JOURNAL  (3 to 9 February 2006):  "Cancer Drug takes an unconventional route"
 

Welcome

Version en Español - Intro
 

Journal of Carcinogenesis (2006):

Cytoreg® inhibits growth and proliferation of human adenocarcinoma cells via induction of apoptosis
 

Society of Toxicology Annual Meeting (New Orleans, 2005), Poster/Abstract:

Evaluation of Cytoreg® Using In Vitro Toxicity Screening in Rat Hepatoma (H4IIE) Cells, Normal Rat Kidney (NRK) Cells, and Rat Primary Hepatocytes
 

Drug Discovery Technology Conference (Boston, 2004), Poster/Abstract:

Effect of Cytoreg^® on Biomarkers in B16-F10 Murine Melanoma
 

Important Notice: This website is intended for informational purposes only. Nothing in this website is intended, or should be understood to make claims regarding the safety or efficiency of any treatments. Unless otherwise indicated, none of the statements in this website have been reviewed or approved by the United States FDA,  or by any other international drug approving agency.  Always consult qualified health care providers for advice about any medical condition or concern.
 

© 2006, Cytorex Biosciences, Inc.